-+ 0.00%
-+ 0.00%
-+ 0.00%

On the 19th, Jietai Technology announced a strategic partnership with Eli Lilly to focus on the research and discovery of novel LNP delivery solutions and explore tissue-specific delivery solutions that support various treatment models. This is the first domestic strategic cooperation around LNP delivery with a generative AI platform as the core driver, and the largest AI-driven extra-hepatic LNP delivery platform cooperation in the world, totaling up to 1.1 billion US dollars.

Zhitongcaijing·10/19/2026 13:41:11
Listen to the news
On the 19th, Jietai Technology announced a strategic partnership with Eli Lilly to focus on the research and discovery of novel LNP delivery solutions and explore tissue-specific delivery solutions that support various treatment models. This is the first domestic strategic cooperation around LNP delivery with a generative AI platform as the core driver, and the largest AI-driven extra-hepatic LNP delivery platform cooperation in the world, totaling up to 1.1 billion US dollars.